Literature DB >> 25616061

A ghrelin receptor agonist is an effective colokinetic in rats with diet-induced constipation.

R V Pustovit1, J B Furness, L R Rivera.   

Abstract

BACKGROUND: Despite constipation being a common problem, the treatments that are available have side effects and are only partly effective. Recent studies show that centrally penetrant ghrelin receptor agonists cause defecation in humans and other species. Here, we describe some features of a rat model of low fiber-induced constipation, and investigate the effectiveness of the ghrelin agonist, capromorelin.
METHODS: Rats were given low-fiber diets for 5 weeks. Their colorectal responsiveness to distension and to a behavioral test, water avoidance and colon histology were compared to those of rats on a standard diet. KEY
RESULTS: After the low-fiber diet, distension of the colon produced fewer propulsive contractions, behaviorally induced defecation was reduced, and the lining of the colorectum was inflamed. However, capromorelin was similarly effective in causing defecation in constipated and non-constipated rats. CONCLUSIONS & INFERENCES: Low-fiber diet in rats produces a constipation phenotype, characterized by reduced responsiveness of the colorectum to distension and to a behavioral stimulus of defecation, water avoidance. The effectiveness of capromorelin suggests that centrally penetrant ghrelin receptor stimulants may be effective in treating constipation.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  capromorelin; constipation; ghrelin; low-fiber diet

Mesh:

Substances:

Year:  2015        PMID: 25616061     DOI: 10.1111/nmo.12517

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  9 in total

1.  Chronic constipation: improved understanding offers a new therapeutic approach.

Authors:  Gareth J Sanger
Journal:  J Physiol       Date:  2016-08-01       Impact factor: 5.182

Review 2.  Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.

Authors:  Gareth J Sanger; John B Furness
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-22       Impact factor: 46.802

3.  Correlation between colonic secretion and colonic motility in rats: Role of ghrelin.

Authors:  Hsien-Hao Huang; Ching-Heng Ting; Yu-Fong Syu; Shi-Chuan Chang; Chih-Yen Chen
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

4.  Evidence that central pathways that mediate defecation utilize ghrelin receptors but do not require endogenous ghrelin.

Authors:  Ruslan V Pustovit; Brid Callaghan; Mitchell T Ringuet; Nicole F Kerr; Billie Hunne; Ian M Smyth; Claudio Pietra; John B Furness
Journal:  Physiol Rep       Date:  2017-08

Review 5.  Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.

Authors:  Paula Mosińska; Hubert Zatorski; Martin Storr; Jakub Fichna
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

6.  The immune-regulating effect of Xiao'er Qixingcha in constipated mice induced by high-heat and high-protein diet.

Authors:  Chang Qu; Guang-Hua Yang; Rong-Bo Zheng; Xiu-Ting Yu; Shao-Zhong Peng; Jian-Hui Xie; Jian-Nan Chen; Xiu-Fen Wang; Zi-Ren Su; Xiao-Jun Zhang
Journal:  BMC Complement Altern Med       Date:  2017-03-31       Impact factor: 3.659

7.  Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats.

Authors:  Artem Minalyan; Lilit Gabrielyan; Claudio Pietra; Yvette Taché; Lixin Wang
Journal:  Front Integr Neurosci       Date:  2019-04-12

Review 8.  Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor.

Authors:  Gianfabio Giorgioni; Fabio Del Bello; Wilma Quaglia; Luca Botticelli; Carlo Cifani; E Micioni Di Bonaventura; M V Micioni Di Bonaventura; Alessandro Piergentili
Journal:  J Med Chem       Date:  2022-02-14       Impact factor: 7.446

9.  Colokinetic effect of noradrenaline in the spinal defecation center: implication for motility disorders.

Authors:  Kiyotada Naitou; Takahiko Shiina; Kurumi Kato; Hiroyuki Nakamori; Yuuki Sano; Yasutake Shimizu
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.